KLOW 80 mg

KL-2026-003Lot QL80PAnalyzed October 27, 2026

Timeline

Ordered

October 20, 2026

Received

October 23, 2026

Analyzed

October 27, 2026

Sample

Name

KLOW 80 mg

Expected

KLOW blend (GHK-Cu, BPC-157, TB-500, KPV)

Amount

1 vial, lyophilized powder

Testing

Client

Flatirons Research Co

Test type

Content & purity

Method

HPLC-UV

Content, how much is in it

GHK-Cu62.3mg

Label claim: 50 mg

BPC-15713.84mg

Label claim: 10 mg

TB-50010.82mg

Label claim: 10 mg

KPV11.88mg

Label claim: 10 mg

Purity, how clean it is

99.5%

Peptide purity, HPLC-UV peak area

Chromatogram

HPLC-UV

11.46 min, BPC-157, 61.5%

12.44 min, TB-500, 38.0%

Analyst Comments

Blue lyophilized powder, clear-cap vial, received sealed. GHK-Cu and KPV were measured on a second HPLC-UV method; the chromatogram shows the BPC-157 / TB-500 method.

Analyst Signature

Max Barrett

Lab Director, PuriLab Analytical

Analysis date: October 27, 2026

Verification Code

KL-GGB6-6UBT

Verify at purilab.org/verify/KL-GGB6-6UBT

Scan to Verify

KL-GGB6-6UBT

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analytical|admin@purilab.org

Page 1 of 1